Insilico Medicine ("Insilico") (3696.HK), a clinical-stage biotechnology company powered by generative artificial ...
Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results